Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00382603 · ClinicalTrials.gov registry record · NA
Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic Patients
A NA study of Contact Lens Care, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 362
- Enrollment target
- 1
- Study location
NCT00382603: Completed NA study of Contact Lens Care, sponsored by Alcon Research.
NCT00382603 is a NA study of Contact Lens Care that has completed, run by Alcon Research. The registered enrollment target is 362 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00382603, a NA study of Contact Lens Care, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 362 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study was to clinically evaluate the safety and effectiveness of a new multi-purpose disinfecting solution for soft contact lenses in patients who experience discomfort with their contact lenses.
Conditions Studied
Interventions
- DEVICE OptiFree Multi-Purpose Disinfecting Solution
Study Locations (1)
Colorado
- Highlands Ranch - Highlands Ranch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 362 participants |
| Start Date | 2004-08 |
| Est. Completion | 2005-02 |
| Phase | NA |
What the finished NCT00382603 record still lists
NCT00382603 is an interventional study that assigns participants to a tested intervention. The registered 362 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 1 condition, with Contact Lens Care appearing as the primary indexed condition, and to 1 intervention - of which OptiFree Multi-Purpose Disinfecting Solution is the first listed.
NCT00382603 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT00382603 about?
NCT00382603 is a clinical study titled "Evaluation of an Investigational Multi-Purpose Disinfecting Solution for the Care of Soft Contact Lenses in Symptomatic Patients". The objective of the study was to clinically evaluate the safety and effectiveness of a new multi-purpose disinfecting solution for soft contact lenses in patients who experience discomfort with their contact lenses.
What is the current status of trial NCT00382603?
This trial is currently completed. It is a NA study. The enrollment target is 362 participants. The study started on 2004-08. Estimated completion is 2005-02.
What conditions does trial NCT00382603 study?
This clinical trial studies the following conditions: Contact Lens Care.
What interventions are being tested in trial NCT00382603?
The interventions under investigation include: OptiFree Multi-Purpose Disinfecting Solution (DEVICE).
Who is sponsoring clinical trial NCT00382603?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00382603 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contact Lens Care
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00382603's enrollment target sits among peer trials
362 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04988555 · 362 participants · Phase 1
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
- NCT05536141 · 362 participants · Phase 1
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
- NCT06534983 · 362 participants · Phase 2
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
- NCT06472245 · 363 participants · Phase 3
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia